A detailed history of Assetmark, Inc transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Assetmark, Inc holds 44,185 shares of IDYA stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,185
Previous 39,704 11.29%
Holding current value
$1.14 Million
Previous $1.39 Million 0.36%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$30.37 - $43.05 $136,087 - $192,907
4,481 Added 11.29%
44,185 $1.4 Million
Q2 2024

Aug 13, 2024

BUY
$34.37 - $43.46 $481,626 - $609,004
14,013 Added 54.54%
39,704 $1.39 Million
Q1 2024

May 06, 2024

BUY
$34.2 - $47.13 $878,632 - $1.21 Million
25,691 New
25,691 $1.13 Million

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.24B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.